Evidence map›Paper›PMID 41477456›Full record

ReviewThe Yale journal of biology and medicine2025

Living with Filariasis: Unseen Struggles of a Neglected Disease.

A Shamema, Praveen Kumar

Abstract readReview
In one paragraph

Review in The Yale journal of biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A ShamemaJawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
Praveen KumarJawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic filariasis (LF) is a long-lasting, debilitating parasitic infection that has remained an immense burden to the endemic areas globally in the realms of physical, psychological, and socioeconomic suffering. LF presents itself in the form of lymphedema, hydrocele, and disfigurement, and limits motor activity, working capabilities, and interaction processes between people, significantly reducing self-esteem and life quality. LF brings significant socio-psychological distress besides the physical one. A decline in self-esteem often results in anxiety and depression; recognizable deformities are stigmatized and avoided. This social isolation and poverty become internalized, also with the misconceptions of contagion and impurity, and further bring about the perpetuation of vulnerability. Gender acts as a multifactor determinant force of the LF experience. It contains multiple layers of discrimination against women, concerning marriage refusal, and the workplace, where men are denied opportunities to earn their living and can become social outcasts. Such inequities, which are gender-based, are expected to be addressed when it comes to managing diseases. Constant obstacles put access to timely treatment and care in the spotlight, including the lack of awareness, financial constraints, and health facilities. The most effective interventions are the extension of the community participation levels and maximization of mass drug administration (MDA), which can considerably decrease the disease and burden of the disease and its burden. The world campaigns towards the abolition should not henceforth be geared towards pharmacological but rather take a rights-based approach. The psychological support, social rehabilitation, and gender-based interventions introduced into the social health systems can increase the inclusion and cost-efficiency of the individuals who have already experienced the widened perceived effects of LF and their dignity.

Indexed as

Elephantiasis, FilarialNeglected DiseasesFemaleHumansMaleQuality of LifeLymphatic filariasisNeglected tropical diseaseSocial stigma

Identifiers

PMID41477456
PMCPMC12742584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.